- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- hetero-3-3-1-mer
- Ligands
- 5 x MG: MAGNESIUM ION(Non-covalent)
- 4 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 14 residues within 4Å:- Chain A: D.170, Q.172, T.173, G.174, K.175, T.176, S.177, F.357, R.362, Q.430, G.431, Q.432
- Chain D: R.376
- Ligands: MG.1
13 PLIP interactions:12 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:Q.172, A:Q.172, A:T.173, A:G.174, A:K.175, A:T.176, A:S.177, A:S.177, A:Q.430, D:R.376
- Water bridges: A:Q.432
- Salt bridges: A:K.175, A:K.175
ATP.4: 16 residues within 4Å:- Chain B: D.170, R.171, Q.172, T.173, G.174, K.175, T.176, S.177, F.357, R.362, Q.430, G.431, Q.432
- Chain E: R.360, D.363
- Ligands: MG.3
15 PLIP interactions:12 interactions with chain B, 3 interactions with chain E- Hydrogen bonds: B:Q.172, B:Q.172, B:T.173, B:G.174, B:K.175, B:T.176, B:S.177, B:S.177, B:Q.430, B:Q.432, B:Q.432, E:R.360, E:D.363, E:D.363
- Salt bridges: B:K.175
ATP.6: 15 residues within 4Å:- Chain C: D.170, R.171, Q.172, T.173, G.174, K.175, T.176, S.177, F.357, P.363, Q.430, G.431, Q.432
- Chain F: M.362
- Ligands: MG.5
14 PLIP interactions:13 interactions with chain C, 1 interactions with chain F- Hydrogen bonds: C:Q.172, C:Q.172, C:T.173, C:G.174, C:K.175, C:T.176, C:S.177, C:S.177, C:Q.430, F:M.362
- Water bridges: C:Q.172, C:Q.432
- Salt bridges: C:K.175, C:K.175
ATP.11: 21 residues within 4Å:- Chain B: I.343, S.344, V.371, R.373
- Chain F: G.161, A.162, G.163, V.164, G.165, K.166, T.167, V.168, E.192, R.193, Y.315, Y.349, F.422, A.425, F.428, T.429
- Ligands: MG.10
16 PLIP interactions:12 interactions with chain F, 4 interactions with chain B- Hydrogen bonds: F:G.163, F:V.164, F:G.165, F:K.166, F:T.167, F:V.168, B:S.344
- Water bridges: F:Y.349, F:Q.420
- Salt bridges: F:K.166, F:K.166, F:R.193, B:R.373, B:R.373, B:R.373
- pi-Stacking: F:Y.349
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.8: 16 residues within 4Å:- Chain C: S.372, R.373
- Chain D: G.161, A.162, G.163, V.164, G.165, K.166, T.167, V.168, Y.349, F.422, A.425, F.428, T.429
- Ligands: MG.7
15 PLIP interactions:12 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: D:G.161, D:G.163, D:V.164, D:G.165, D:K.166, D:T.167, D:V.168, C:S.372
- Water bridges: D:K.166, D:K.166, D:R.193
- Salt bridges: D:K.166, C:R.373, C:R.373
- pi-Stacking: D:Y.349
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Orriss, G.L. et al., Bovine F1-ATPase covalently inhibited with 4-chloro-7-nitrobenzofurazan: the structure provides further support for a rotary catalytic mechanism. Structure (1998)
- Release Date
- 1998-08-26
- Peptides
- F1-ATPASE: ABC
F1-ATPASE: DEF
F1-ATPASE: G - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
G
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- hetero-3-3-1-mer
- Ligands
- 5 x MG: MAGNESIUM ION(Non-covalent)
- 4 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Orriss, G.L. et al., Bovine F1-ATPase covalently inhibited with 4-chloro-7-nitrobenzofurazan: the structure provides further support for a rotary catalytic mechanism. Structure (1998)
- Release Date
- 1998-08-26
- Peptides
- F1-ATPASE: ABC
F1-ATPASE: DEF
F1-ATPASE: G - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
G